Hospital Universitario La Paz-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2010

  1. Compatibility and stability of ternary admixtures of tramadol, haloperidol, and hyoscine N-butyl bromide: Retrospective clinical evaluation

    Journal of Palliative Medicine, Vol. 13, Núm. 3, pp. 273-277

2007

  1. Tramadol and hyoscine N-butyl bromide combined in infusion solutions: Compatibility and stability

    Supportive Care in Cancer, Vol. 15, Núm. 1, pp. 57-62

2006

  1. Compatibility and stability of furosemide and dexamethasone combined in infusion solutions

    Arzneimittel-Forschung/Drug Research, Vol. 56, Núm. 10, pp. 714-720

  2. Morphine, haloperidol and hyoscine N-butyl bromide combined in s.c. infusion solutions: Compatibility and stability. Evaluation in terminal oncology patients

    International Journal of Pharmaceutics, Vol. 307, Núm. 2, pp. 278-284

2005

  1. Influence of medium and temperature on the hydrolysis kinetics of propacetamol hydrochloride: Determination using derivative spectrophotometry

    Chemical and Pharmaceutical Bulletin, Vol. 53, Núm. 3, pp. 277-280

  2. Stability and compatibility of binary mixtures of morphine hydrochloride with hyoscine-n-butyl bromide

    Supportive Care in Cancer, Vol. 13, Núm. 4, pp. 239-245

  3. Stability of tramadol and haloperidol for continuous subcutaneous infusion at home

    Journal of Pain and Symptom Management, Vol. 30, Núm. 2, pp. 192-199

2003

  1. Compatibility of haloperidol and hyoscine-N-butyl bromide in mixtures for subcutaneous infusion to cancer patients in palliative care

    Supportive Care in Cancer, Vol. 11, Núm. 2, pp. 107-113

2002

  1. Physical compatibility and in vivo evaluation of drug mixtures for subcutaneous infusion to cancer patients in palliative care

    Supportive Care in Cancer, Vol. 10, Núm. 1, pp. 65-70